,i #aahth ,,congress #ast ,session ,h4 ,r4 #ahbg ,,in ,,the ,,house ,,of ,,representatives ,march #bh1 #bjbc,mr4 ,carter of ,georgia 7for himself1 ,mr4 ,cuellar1 and ,mr4 ,gallagher7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce ,a ,,bill ,to prohibit the ,national ,institutes of ,health from conducting or supporting certain gain-of-function research1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,pausing ,enhanced ,pandemic ,pathogen ,research ,act of #bjbc4 #b4 ,no conduct or support by ,,nih of gain-of-function research ,part ,a of title ,,iv of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bha et seq47 is amended by adding at the end the following3 #djd,p4 ,gain-of-function research 7a7 ,prohibition ,during the period ending on ,march #cj1 #bjbh1 the ,national ,institutes of ,health shall not conduct or support1 directly or indirectly1 including through subgrants1 any gain-of-function research4 7b7 ,limitation ,this section does not apply to characterization or testing of any naturally occurring influenza virus or coronavirus1 unless the characterization or testing could increase pathogenicity or transmissibility4 7c7 ,gain-of-,function research defined ,in this section1 the term gain-of-function research means any research that could enhance the transmissibility1 virulence1 or pathogenicity of any pathogen 7whether or not classified as a pathogen of pandemic potential7 or non-pathogen agent in a way that could result in one or more of the following3 7#a7 ,the pathogen or agent becoming moderately or highly transmissible1 virulent1 or pathogenic in human populations4 7#b7 ,the pathogen or agent causing significant morbidity or mortality in humans4 7#c7 ,the pathogen or agent posing a severe threat to public health1 the capacity of public health systems1 or the national security of the ,united ,states4 4